CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Millions	Total	Redeemable Noncontrolling Interest	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Treasury stock	Retained Earnings
Beginning balance at Apr. 29, 2023	$ 941.8		$ 18.6	$ 181.0	$ (19.0)	$ (11.5)	$ 772.7
Beginning balance (in shares) at Apr. 29, 2023			37,167,375
Beginning balance at Apr. 29, 2023		$ 11.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock, net of tax withholding	(3.8)		$ 0.1	(0.1)			(3.8)
Issuance of restricted stock, net of tax withholding (in shares)			189,454
Purchase of redeemable noncontrolling interest		(11.1)
Purchases of common stock	$ (7.8)		$ (0.2)				(7.6)
Purchases of common stock (in shares)	(322,779)		(322,779)
Stock-based compensation expense	$ 2.9			2.9
Other comprehensive loss	(23.9)				(23.9)
Net loss	(54.4)						(54.4)
Dividends on common stock	(9.9)						(9.9)
Ending balance at Oct. 28, 2023	844.9		$ 18.5	183.8	(42.9)	(11.5)	697.0
Ending balance (in shares) at Oct. 28, 2023			37,034,050
Beginning balance at Jul. 29, 2023	931.4		$ 18.7	182.5	(23.1)	(11.5)	764.8
Beginning balance (in shares) at Jul. 29, 2023			37,356,156
Beginning balance at Jul. 29, 2023		0.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock, net of tax withholding (in shares)			673
Purchase of redeemable noncontrolling interest		$ (0.9)
Purchases of common stock	$ (7.8)		$ (0.2)				(7.6)
Purchases of common stock (in shares)	(322,779)		(322,779)
Stock-based compensation expense	$ 1.3			1.3
Other comprehensive loss	(19.8)				(19.8)
Net loss	(55.3)						(55.3)
Dividends on common stock	(4.9)						(4.9)
Ending balance at Oct. 28, 2023	844.9		$ 18.5	183.8	(42.9)	(11.5)	697.0
Ending balance (in shares) at Oct. 28, 2023			37,034,050
Beginning balance at Apr. 27, 2024	766.0		$ 18.3	183.6	(36.7)	(11.5)	612.3
Beginning balance (in shares) at Apr. 27, 2024			36,650,909
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock, net of tax withholding	(0.3)		$ 0.1	0.1			(0.5)
Issuance of restricted stock, net of tax withholding (in shares)			185,923
Cancellation of restricted stock (in shares)			(79,325)
Conversion of cash bonus to RSUs	2.1			2.1
Purchases of common stock	$ (1.6)		$ (0.1)				(1.5)
Purchases of common stock (in shares)	(136,000)		(136,000)
Stock-based compensation expense	$ 2.8			2.8
Other comprehensive loss	(1.0)				(1.0)
Net loss	(19.9)						(19.9)
Dividends on common stock	(9.8)						(9.8)
Ending balance at Nov. 02, 2024	738.3		$ 18.3	188.6	(37.7)	(11.5)	580.6
Ending balance (in shares) at Nov. 02, 2024			36,621,507
Beginning balance at Jul. 27, 2024	744.4		$ 18.3	186.8	(36.3)	(11.5)	587.1
Beginning balance (in shares) at Jul. 27, 2024			36,591,684
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of restricted stock, net of tax withholding	0.2			0.2
Issuance of restricted stock, net of tax withholding (in shares)			29,823
Conversion of cash bonus to RSUs	0.1			0.1
Purchases of common stock	$ 0.0
Purchases of common stock (in shares)	0
Stock-based compensation expense	$ 1.5			1.5
Other comprehensive loss	(1.4)				(1.4)
Net loss	(1.6)						(1.6)
Dividends on common stock	(4.9)						(4.9)
Ending balance at Nov. 02, 2024	$ 738.3		$ 18.3	$ 188.6	$ (37.7)	$ (11.5)	$ 580.6
Ending balance (in shares) at Nov. 02, 2024			36,621,507